Safety and Immunogenicity in Adults of Revaccination With Adacel Vaccine 10 Years After a Previous Dose.
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2018
At a glance
- Drugs DTaP vaccine (Primary) ; Diphtheria-tetanus vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 12 Mar 2018 Results reporting antibody persistence through 10 years after vaccination, published in the Vaccine Journal.
- 25 Apr 2017 Status changed from active, no longer recruiting to completed.
- 08 Sep 2015 Planned End Date changed from 1 Mar 2014 to 1 Oct 2016 as reported by ClinicalTrials.gov.